Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

48.20
BATS BZX Real-Time Price
As of 1:50pm ET
 -0.26 / -0.54%
Today’s Change
36.81
Today|||52-Week Range
50.24
+19.19%
Year-to-Date
One of the 33 Great Minds of Investing
Aug 21 / GuruFocus News - Paid Partner Content
Mylan Finalizes $465 Million EpiPen Settlement With DoJ
Aug 17 / TheStreet.com - Paid Partner Content
Biogen & 6 Other Multiple Sclerosis Drug Stocks in Focus: Here's Why
Aug 21 / Zacks.com - Paid Partner Content
Regeneron's (REGN) RSV Drug Suptavumab Fails NURSERY Trial
Aug 16 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning
Aug 18 / Zacks.com - Paid Partner Content
Spectrum (SPPI) Initiates Phase II Study for Cancer Drug
Aug 16 / Zacks.com - Paid Partner Content
European Pharma Companies Slip on MS Pricing Probe
Aug 18 / TheStreet.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Seattle Genetics' Adcetris Granted Priority Review by FDA
Aug 17 / Zacks.com - Paid Partner Content
Cullen Capital Management, LLC Buys Globaltrans Investment PLC, Smurfit Kappa Group P...
Aug 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close48.46
Today’s open48.39
Day’s range48.19 - 48.39
Volume18,790
Average volume (3 months)1,670,343
Market cap$121.7B
Dividend yield3.40%
Data as of 1:50pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-2.08%
P/E ratio26.0
Price/Sales2.81
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.31-0.43%
CELGCelgene-0.94-0.72%
GSKGlaxoSmithKline+0.08+0.20%
BMYBristol-Myers Squibb+0.15+0.26%
Data as of 1:54pm ET, 08/23/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.02
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts